Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

KRAS-specific inhibition using a DARPin binding to a site in the allosteric lobe.

Journal article

Bery N. et al, (2019), Nat Commun, 10

Bioluminescence Resonance Energy Transfer 2 (BRET2)-Based RAS Biosensors to Characterize RAS Inhibitors.

Journal article

Bery N. and Rabbitts TH., (2019), Curr Protoc Cell Biol, 83

Lipid-mRNA Nanoparticle Designed to Enhance Intracellular Delivery Mediated by Shock Waves.

Journal article

Zhang J. et al, (2019), ACS Appl Mater Interfaces, 11, 10481 - 10491

Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compounds.

Journal article

Cruz-Migoni A. et al, (2019), Proc Natl Acad Sci U S A, 116, 2545 - 2550

Selection and Characterization of a Nanobody Biosensor of GTP-Bound RHO Activities.

Journal article

Keller L. et al, (2019), Antibodies (Basel), 8

Cloning, purification and structure determination of the HIV integrase-binding domain of lens epithelium-derived growth factor.

Journal article

Hannon C. et al, (2018), Acta Crystallogr F Struct Biol Commun, 74, 143 - 149

From intracellular antibody fragments to small molecule inhibitors of mutant KRAS

Journal article

Quevedo CE. et al, (2017), CANCER RESEARCH, 77

LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma.

Journal article

Jain A. et al, (2017), Clin Oncol (Belmont), 2

Exploring the surfaceome of Ewing sarcoma identifies a new and unique therapeutic target.

Journal article

Town J. et al, (2016), Proc Natl Acad Sci U S A, 113, 3603 - 3608

LMO2 at 25 years: a paradigm of chromosomal translocation proteins.

Journal article

Chambers J. and Rabbitts TH., (2015), Open Biol, 5

Load More